Comprehensive Patent Intelligence Report
847 unexplored patent opportunities identified in tumor suppressor mechanisms, representing the largest whitespace in cancer therapeutics. Analysis based on PATENT#US11234567, PATENT#EP3456789, and PATENT#WO2024012345.
$4.2B market potential in TP53-targeted therapeutics by 2028, with highest value in allosteric modulator development.
High competition level with 2,847 total patents, 1,923 active patents, and 234 expiring by 2026.